MPS Code: 0519/2022

About the course

Over the years, beta-blockers and calcium channel blockers have been the backbone of antianginal therapy, yet some patients continue to be symptomatic. Thus, second-line antianginal therapy is required to reduce angina attacks and nitroglycerin use. Upon completion of this module, participants will gain insights into the following aspects:

• Prevalence and burden of angina pectoris
• Latest guidelines on the management of stable coronary artery disease
• Efficacy of a second-line antianginal agent in patients with frequent angina attacks

CPD Reviewer:
Professor Chee Kok Han
Senior Consultant Cardiologist
University Malaya Medical Centre

Who should participate:
Pharmacists

NOTE:
Please read thoroughly & understand the module before attempting the assessment questions.

Terms & Conditions:

• Participants must obtain a minimum score of 7/10 (70%) to be awarded 1 point.
• MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points.

The modules/articles are best viewed with:
Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards-compliant browser may be required to view the modules.

Sponsored by